Abstract
The treatment of fungal infections of the central nervous system is impaired by the limited number of antifungal agents available and by the fact that their efficacy depends on their penetration into the cerebrospinal fluid (CSF). Patients with neuromycoses frequently present complex clinical signs and symptoms and may require individualized treatment including the monitoring of drug leve…